Wolfgang Mueller

The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway

5-HT3 receptor antagonist for the treatment of tendinopathy

Treatment of non-pathogen induced skin diseases, e.g. chronic eczema, neurodermatitis, psoriasis, urticaria or burns, by blockade of the 5HT-3 receptor, e.g. using tropisetron

Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia

Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases

Verwendung von antagonisten der 5-ht3-rezeptoren zur behandlung von muskuloeskeletalen erkrankungen Use of antagonists of 5-HT3 receptors for the treatment of diseases muskuloeskeletalen

Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome

Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia

Utilisations d'antagonistes de substance p pour le traitement du syndrome de la fatigue chronique et/ou de la fibromyalgie et utilisation des antagnistes du recepteur nk-1 pour letraitement du syndrome de la fatigue chronique

Verwendung von substanz p antagonisten zur behandlung des chronischen ermüdungssyndroms und/oder der fibromyalgie Use of substance P antagonists for the treatment of chronic fatigue syndrome and / or fibromyalgia